Skip to main content

Table 3 APOE and CSF biomarker baseline descriptives by syndrome diagnosis

From: The Dutch Parelsnoer Institute - Neurodegenerative diseases; methods, design and baseline results

  Subjective complaints MCI Dementia
APOE genotype    
  APOE N 159 208 294
  e4 noncarrier 96 (60%) 97 (47%) 137 (47%)
  e4 heterozygous 51 (32%) 90 (43%) 124 (42%)
  e4 homozygous 12 (8%) 19 (9%) 29 (10%)
CSF biomarkers    
  CSF biomarker N 60 67 84
  Amyloid-beta 1-42 817 ± 252 692 ± 290 610 ± 258
  Total tau 286 ± 170 473 ± 257 514 ± 277
  Ptau 38 ± 18 53 ± 26 57 ± 26
  1. Data are presented as mean ± sd. Please note that while raw CSF biomarker values are presented, statistical analyses were performed using log-transformed values.